Crescent Capital BDC (CCAP) Stock Price, News & Analysis

Company Overview

Crescent Capital BDC, Inc. (NASDAQ: CCAP) is a business development company that provides financing to privately owned, primarily middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by investing in debt and equity securities.

Crescent Capital BDC generally focuses on senior secured loans, subordinated debt and other credit investments. Its portfolio companies operate across a range of industries, and the company may provide financing for acquisitions, recapitalizations, refinancing transactions, growth initiatives and other corporate purposes.

The company is externally managed by Crescent Capital Group LP, an investment management firm specializing in credit and private capital strategies. Crescent Capital BDC serves businesses primarily in the United States and uses the investment and underwriting resources of its manager to identify and manage middle-market investments.

Key Stats

• Today's Range: $9.74 to $10.15
• 50-Day Range: $9.78 to $11.77
• 52-Week Range: $9.74 to $15.77
• Volume: 697,611 shs
• Average Volume: 269,884 shs
• Market Capitalization: $360.39 million
• P/E Ratio: N/A
• Dividend Yield: 13.91%
• Price Target: $12.63
• Consensus Rating: Hold

Crescent Capital BDC Stock Analysis - MarketRank™

Crescent Capital BDC scored higher than 85% of companies evaluated by MarketBeat, and ranked 140th out of 846 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Hold

Consensus Rating

Crescent Capital BDC has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no strong buy ratings, 1 buy rating, 6 hold ratings, and no sell ratings.

Upside Potential

Crescent Capital BDC has a consensus price target of $12.63, representing about 29.1% upside from its current price of $9.78.

Amount of Analyst Coverage

Crescent Capital BDC has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -5.37%

Earnings Growth

Earnings for Crescent Capital BDC are expected to decrease by -5.37% in the coming year, from $1.49 to $1.41 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Crescent Capital BDC is -108.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Crescent Capital BDC is -108.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Crescent Capital BDC has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.80% of the float of Crescent Capital BDC has been sold short.

Short Interest Ratio / Days to Cover

Crescent Capital BDC has a short interest ratio ("days to cover") of 2.86, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Crescent Capital BDC has recently decreased by 8.45%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Crescent Capital BDC is a leading dividend payer. It pays a dividend yield of 13.48%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Crescent Capital BDC has only been increasing its dividend for 1 years.

Dividend Sustainability

Based on EPS estimates, Crescent Capital BDC will have a dividend payout ratio of 96.45% in the coming year. This indicates that Crescent Capital BDC may not be able to sustain their current dividend.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Crescent Capital BDC this week, compared to 3 articles on an average week.

Search Interest

8 people have searched for CCAP on MarketBeat in the last 30 days. This is an increase of 700% compared to the previous 30 days.

MarketBeat Follows

2 people have added Crescent Capital BDC to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.8 / 5
• Insider Trading: Selling Shares

Cluster Insider Buying

2 insiders have purchased shares of Crescent Capital BDC in the last three months. Multiple insiders buying is a strong bullish signal.

Insider Buying vs. Insider Selling

In the past three months, Crescent Capital BDC insiders have sold 9,462.11% more of their company's stock than they have bought. Specifically, they have bought $49,045.00 in company stock and sold $4,689,738.00 in company stock.

Percentage Held by Insiders

1.23% of the stock of Crescent Capital BDC is held by insiders.

Percentage Held by Institutions

49.46% of the stock of Crescent Capital BDC is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/10/2026
• Record date for 9/15 Dividend: 8/31/2026
• Ex-Dividend for 9/15 Dividend: 8/31/2026
• Dividend Payable: 9/15/2026
• Today: 9/19/2026
• Record date for 10/15 Dividend: 9/30/2026
• Ex-Dividend for 10/15 Dividend: 9/30/2026
• Dividend Payable: 10/15/2026
• Next Earnings (Estimated): 11/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Capital Markets
• Sub-Industry: Asset Management & Custody Banks
• Current Symbol: NASDAQ:CCAP
• CIK: 1633336
• Web: www.crescentbdc.com
• Phone: 310-235-5900
• Fax: N/A
• Employees: 250
• Year Founded: 2019

Price Target and Rating

• Average Price Target for Crescent Capital BDC: $12.63
• High Price Target: $16.00
• Low Price Target: $10.25
• Potential Upside/Downside: +29.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.14
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 6.56
• P/E Growth: N/A
• Net Income: $34.51 million
• Net Margins: -2.02%
• Pretax Margin: 40.82%
• Return on Equity: 9.02%
• Return on Assets: 3.82%

Debt

• Debt-to-Equity Ratio: 1.41
• Current Ratio: 1.30
• Quick Ratio: 1.30

Sales & Book Value

• Annual Sales: $167.29 million
• Price / Sales: 2.15
• Cash Flow: $1.66 per share
• Price / Cash Flow: 5.88
• Book Value: $19.09 per share
• Price / Book: 0.51

Miscellaneous

• Outstanding Shares: 36,850,000
• Free Float: 36,393,000
• Market Cap: $360.39 million
• Optionable: Not Optionable
• Beta: 0.52